US Patent Issued to University of Kentucky Research Foundation on April 14 for "Substituted N-benzhydrylacetamide inhibitors of jumanji domain histone demethylases for the treatment of cancer" (Kentucky Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,597, issued on April 14, was assigned to University of Kentucky Research Foundation (Lexington, Ky.).

"Substituted N-benzhydrylacetamide inhibitors of jumanji domain histone demethylases for the treatment of cancer" was invented by Chunming Liu (Lexington, Ky.), David S. Watt (Lexington, Ky.), Wen Zhang (Lexington, Ky.) and Vitaliy M. Sviripa (Lexington, Ky.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds for inhibiting Wnt signaling and methods of treating cancer. The compounds include any compound having a structure according to Formula II. The method includes administering one or more compounds according to Formula I...